AIDS Cure Research: North Carolina Scientist Study Cancer Drug - AIDSmeds.com HIV/AIDS Treatment News

AIDS Cure Research: North Carolina Scientist Study Cancer Drug
AIDSmeds.com HIV/AIDS Treatment News
The drug, called Zolinza (vorinostat), is part of a family of drugs known as histone deacetylase (HDAC) inhibitors. Previous research found that Zolinza was ...

and more »

continue reading

AIDS Quest to Kill `Sleeping' Virus Enlists Merck Cancer Drug - Bloomberg


Kansas City Star
AIDS Quest to Kill `Sleeping' Virus Enlists Merck Cancer Drug
Bloomberg
Merck supports the study, and is continuing its own research on other drugs that it might be able to combine with HDAC inhibitors, Hazuda said. ...
Researchers to test Merck cancer drug on HIV The Star-Ledger - NJ.com

all 128 news articles »

continue reading

Translational medicine provides new insight for treating cutaneous lymphomas - ModernMedicine

Translational medicine provides new insight for treating cutaneous lymphomas
ModernMedicine
Boston — Clinical observations from the use of immune modulators and histone deacetylase (HDAC) inhibitors are providing researchers with clues into the ...

continue reading

Syndax Pharmaceuticals Secures $6 Million in Securities Offering - Trading Markets (press release)

Syndax Pharmaceuticals Secures $6 Million in Securities Offering
Trading Markets (press release)
Syndax said that Entinostat is an orally bioavailable, highly selective, class I histone deacetylase (HDAC) inhibitor with a long half-life that allows for ...

continue reading

Epigenetic Therapies are Synergistic with Conventional Treatments - About - News & Issues (blog)

Epigenetic Therapies are Synergistic with Conventional Treatments
About - News & Issues (blog)
Also, as was observed for some HDAC inhibitors, reduced DNA repair efficiency may enhance radiation treatments by increasing cellular radiosensitivity. ...

continue reading

MethylGene Appoints Dr. Martin Godbout as Chairman of the Board of Directors - MarketWatch (press release)

MethylGene Appoints Dr. Martin Godbout as Chairman of the Board of Directors
MarketWatch (press release)
A fourth compound discovered using MethylGene's HDAC platform, EVP-0334 - a potential cognition enhancing agent for neurodegenerative diseases has ...

and more »

continue reading

MethylGene Announces Change to the Board of Directors - MarketWatch (press release)

MethylGene Announces Change to the Board of Directors
MarketWatch (press release)
A fourth compound discovered using MethylGene's HDAC platform, EVP-0334 - a potential cognition enhancing agent for neurodegenerative diseases has ...

and more »

continue reading

$13M funding for health-related research projects across Canada - Laboratory Products News

$13M funding for health-related research projects across Canada
Laboratory Products News
Control of newly synthesized histone deacetylation and its implications for the clinical use of HDAC inhibitors. Verreault, Alain AC. ...

continue reading

Syndax Pharmaceuticals Raises $6 Million in Securities Offering - MarketWatch (press release)

Syndax Pharmaceuticals Raises $6 Million in Securities Offering
MarketWatch (press release)
Entinostat is an orally bioavailable, highly selective, class I histone deacetylase (HDAC) inhibitor with a long half-life that allows for weekly or ...

and more »

continue reading

Chroma Therapeutics Advances Novel Targeted Agent into Development; Receives ... - Lifescience-online

Chroma Therapeutics Advances Novel Targeted Agent into Development; Receives ...
Lifescience-online
Chroma Therapeutics Limited announced today that it had advanced its novel macrophage-targeted HDAC inhibitor, CHR-5154, into preclinical development, ...

continue reading

Oral Yeast Infections

Our Services

Do not forget to check the lastest products and auctions related to Histone Deacetylase Inhibitor as well as our free videos and podcasts.

best Histone Deacetylase Inhibitor products current Histone Deacetylase Inhibitor auctions current Histone Deacetylase Inhibitor videos listen to Histone Deacetylase Inhibitor podcasts

This Day In History

William McKinley: US president was shot by an anarchist; he died eight days later (1901)

Latest Posts